# Multicenter, Safety Study Of Maraviroc

> **NCT00478231** · PHASE3 · COMPLETED · sponsor: **ViiV Healthcare** · enrollment: 209 (actual)

## Conditions studied

- Acquired Immunodeficiency Syndrome
- HIV Infection

## Interventions

- **DRUG:** Maraviroc

## Key facts

- **NCT ID:** NCT00478231
- **Lead sponsor:** ViiV Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2010-08
- **Final completion:** 2010-09
- **Target enrollment:** 209 (ACTUAL)
- **Last updated:** 2011-09-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00478231

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00478231, "Multicenter, Safety Study Of Maraviroc". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00478231. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*